eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
EFFECT

EFFECT

Other
3/A

An amendment to a 3 filing. Non-EDGAR filing

3,4,5
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
S-3

Simplified registration form

Registration Statements
SC 13D/A

An amendment to a SC 13D filing

3,4,5

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]